Pathway diagrams reveal upregulation of a majority of genes in “Pathways in cancer” and “Breast cancer” for PDE10A-HIGH expressing ovarian tumors from the TCGA (with both log-fold and perturbation analyses), whereas PDE10A KO clones show downregulation of many of these genes (Fig. S7). This evidence concerns the gene PDE10A and breast cancer.